EPCAM and neoplasm: Unfortunately, the expression of EpCAM and other surface markers on CTCs is inevitably heterogeneous in real samples.[22, 23] For instance, those CTCs undergoing epithelial to mesenchymal transition (EMT) during tumor progression, would exhibit downregulated EpCAM expression.